Periodontal tissue regeneration with PRP incorporated gelatin hydrogel sponges.
Gelatin hydrogels have been designed and prepared for the controlled release of the transforming growth factor (TGF-b1) and the platelet-derived growth factor (PDGF-BB). PRP (Platelet rich plasma) contains many growth factors including the PDGF and TGF-b1. The objective of this study was to evaluate the regeneration of periodontal tissue following the controlled release of growth factors in PRP. For the periodontal ligament cells and osteoblast, PRP of different concentrations was added. The assessment of DNA, mitochondrial activity and ALP activity were measured. To evaluate the TGF-β1 release from PRP incorporated gelatin sponge, amounts of TGF-β1 in each supernatant sample were determined by the ELISA. Transplantation experiments to prepare a bone defect in a rat alveolar bone were an implanted gelatin sponge incorporated with different concentration PRP. In DNA assay and MTT assay, after the addition of PRP to the periodontal ligament cells and osteoblast, the cell count and mitochondrial activity had increased the most in the group with the addition of 5  ×  PRP. In the ALP assay, after the addition of PRP to the periodontal ligament cells, the cell activity had increased the most in the group with the addition of 3  ×  PRP. In the transplantation, the size of the bone regenerated in the defect with 3  ×  PRP incorporated gelatin sponge was larger than that of the other group.
Department of Periodontology, The Nippon Dental University, Japan.
Dai
D
Nakajima
Yasuhiko
Y
Tabata
Soh
S
Sato
D000818:Animals; D004343:Drug Implants / Q000008:administration & dosage* / Q000138:chemical synthesis; D019544:Equipment Failure Analysis; D005780:Gelatin / Q000737:chemistry*; D016557:Guided Tissue Regeneration, Periodontal / Q000295:instrumentation* / Q000379:methods; D020100:Hydrogels / Q000737:chemistry; D036341:Intercellular Signaling Peptides and Proteins / Q000008:administration & dosage*; D008297:Male; D010510:Periodontal Diseases / Q000188:drug therapy* / Q000473:pathology; D053657:Platelet-Rich Plasma / Q000737:chemistry*; D011474:Prosthesis Design; D051381:Rats; D011916:Rats, Inbred F344; D016896:Treatment Outcome
D004343:Drug Implants; D020100:Hydrogels; D036341:Intercellular Signaling Peptides and Proteins; D005780:Gelatin